GM Biotech logo   sitemap  


home / investor / financial information

Great Management. Great Products. Greater Good

A summary of GM Biotech's current financial position. Please contact our PR department for more information.


GM Biotech's strong product range and dynamic management team have lead to increasing sales year on year.

A highly focused PR department has kept our organisation in a favourable light, reducing the marketing spend considerably.

Aggressive selling in the field has produced heavy take up of our product range.

Cash reserves stand at $200 million.
Assets value at $2 billion.
Total outstanding debt $700 million.
Turn-over $500 million.
Profit before tax $150 million.


© 2002 GM Biotech / legal info / site terms / privacy / designed by firemouth / merchandise